Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Last Updated on: 20 April, 2024|Author: Getaka | Social: X Twitter Profile
Stock Ticker - BSE: 543943 | NSE: ASARFI

Fundamental Analysis of Asarfi Hospital Ltd

Basic Stock Data

Last Updated: April 19, 2024, 11:11 pm

Market Cap 153 Cr.
Current Price 77.7
High / Low146/55.5
Stock P/E19.1
Book Value 34.4
Dividend Yield0.00 %
ROCE26.2 %
ROE24.9 %
Face Value 10.0

Data Source:

Competitors of Asarfi Hospital Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Industry Average0 Cr0000%0%0%0

Quarterly Result

MonthSep 2022Sep 2023
Operating Profit9.318.10
OPM %26.23%20.09%
Other Income0.250.88
Profit before tax7.093.25
Tax %25.39%36.31%
Net Profit5.292.07
EPS in Rs7.061.05

Last Updated: April 10, 2024, 6:09 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: April 5, 2024, 9:18 am

MonthMar 2020Mar 2021Mar 2022Mar 2023
Operating Profit6.248.0410.7813.77
OPM %14.56%14.86%16.54%20.01%
Other Income0.290.280.982.33
Profit before tax3.584.787.7110.89
Tax %26.54%25.94%25.81%26.35%
Net Profit2.633.535.738.02
EPS in Rs21.4828.8346.795.53
Dividend Payout %0.00%0.00%0.00%0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

YoY Net Profit Growth (%)34.22%62.32%39.97%
Change in YoY Net Profit Growth (%)0.00%28.10%-22.36%


Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:17%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:45%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:%
1 Year:%
Return on Equity
10 Years:%
5 Years:%
3 Years:26%
Last Year:25%

Last Updated: April 16, 2024, 1:28 pm

Balance Sheet

MonthMar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital1.251.251.2514.5019.35
Other Liabilities8.8313.2628.4534.3855.89
Total Liabilities27.6437.2962.7193.43155.59
Fixed Assets18.4022.4230.8738.5793.79
Other Assets9.0513.2522.5036.9561.71
Total Assets27.6437.2962.7193.43155.59

Reserves and Borrowings Chart

Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 2.4210.299.26-2.07
Cash from Investing Activity -4.84-16.00-23.16-13.65
Cash from Financing Activity 2.426.0013.7716.82
Net Cash Flow0.000.29-0.131.10

Free Cash Flow

MonthMar 2020Mar 2021Mar 2022Mar 2023
Free Cash Flow0.800.91-0.85-3.43

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2020Mar 2021Mar 2022Mar 2023
Debtor Days20.0114.1629.8489.80
Inventory Days23.1213.2015.5025.89
Days Payable155.8022.6934.1390.98
Cash Conversion Cycle-112.674.6711.2224.72
Working Capital Days18.05-7.15-4.2078.56
ROCE %25.26%28.86%26.21%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2023
No. of Shareholders706

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

MonthMar 23Mar 22Mar 21
Basic EPS (Rs.)7.587.644.71
Diluted EPS (Rs.)7.587.644.71
Cash EPS (Rs.)8.2072.6351.59
Book Value[Excl.RevalReserv]/Share (Rs.)28.86181.09135.25
Book Value[Incl.RevalReserv]/Share (Rs.)28.86181.09135.25
Revenue From Operations / Share (Rs.)48.77521.91433.15
PBDIT / Share (Rs.)11.1194.1666.53
PBIT / Share (Rs.)8.4367.3843.22
PBT / Share (Rs.)7.5161.7638.20
Net Profit / Share (Rs.)5.5345.8428.29
PBDIT Margin (%)22.7718.0415.35
PBIT Margin (%)17.2912.909.97
PBT Margin (%)15.4011.838.82
Net Profit Margin (%)11.338.786.53
Return on Networth / Equity (%)19.1525.3120.91
Return on Capital Employeed (%)16.5517.5618.84
Return On Assets (%)8.579.139.47
Long Term Debt / Equity (X)
Total Debt / Equity (X)0.410.510.42
Asset Turnover Ratio (%)0.901.300.00
Current Ratio (X)1.861.501.12
Quick Ratio (X)1.791.421.03
Inventory Turnover Ratio (X)10.3014.470.00
Interest Coverage Ratio (X)12.0316.7613.26
Interest Coverage Ratio (Post Tax) (X)6.999.166.64

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value: 166.88

The stock is undervalued by 114.77% compared to the current price ₹77.7

Calculation basis:

  • Fair value = (P/E Ratio * (Return on Equity / 100) * Book Value) * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

*Investments are subject to market risks

Strength and Weakness

  1. The stock has a high average ROCE of 20.08%, which is a positive sign.
  2. The stock has a low average Working Capital Days of 21.32, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -18.02, which is a positive sign.
  4. The company has higher reserves (24.97 cr) compared to borrowings (14.68 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (57.75 cr) and profit (6.74 cr) over the years.

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Asarfi Hospital Ltd:
      1. Net Profit Margin: 11.33%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 16.55% (Industry Average ROCE: 0%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 19.15% (Industry Average ROE: 0%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 6.99
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 1.79
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 19.1 (Industry average Stock P/E: 0)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. ✓ Total Debt / Equity: 0.41
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating: ★★★★☆

    About the Company

    Hospitals & Medical Services
    Baramuri, Bishunpur Polytechnic, Dhanbad Jharkand 828130Mr.Udai%20Pratap%20Singh
    NamePosition Held
    Ms. Madhuri SinghExecutive Director
    Mr. Sukanti Kumar DasNon Executive Director
    Mr. Amit Kumar BarnwalIndependent Director
    Ms. Rajkumari SharmaIndependent Director

    Asarfi Hospital Ltd. Share Price Update

    Share PriceValue
    Previous Day₹81.17


    What is the latest fair value of Asarfi Hospital Ltd?

    The latest fair value of Asarfi Hospital Ltd is 166.88.

    What is the Market Cap of Asarfi Hospital Ltd?

    The Market Cap of Asarfi Hospital Ltd is 153 Cr..

    What is the current Stock Price of Asarfi Hospital Ltd as on 19 April 2024?

    The current stock price of Asarfi Hospital Ltd as on 19 April 2024 is 77.7.

    What is the High / Low of Asarfi Hospital Ltd stocks in FY 2024?

    In FY 2024, the High / Low of Asarfi Hospital Ltd stocks is ₹146/55.5.

    What is the Stock P/E of Asarfi Hospital Ltd?

    The Stock P/E of Asarfi Hospital Ltd is 19.1.

    What is the Book Value of Asarfi Hospital Ltd?

    The Book Value of Asarfi Hospital Ltd is 34.4.

    What is the Dividend Yield of Asarfi Hospital Ltd?

    The Dividend Yield of Asarfi Hospital Ltd is 0.00 %.

    What is the ROCE of Asarfi Hospital Ltd?

    The ROCE of Asarfi Hospital Ltd is 26.2 %.

    What is the ROE of Asarfi Hospital Ltd?

    The ROE of Asarfi Hospital Ltd is 24.9 %.

    What is the Face Value of Asarfi Hospital Ltd?

    The Face Value of Asarfi Hospital Ltd is 10.0.

    About the Author

    Author Avatar

    Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Asarfi Hospital Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE